Viemed Healthcare, Inc. (VMD)

NASDAQ: VMD · IEX Real-Time Price · USD
9.43
+0.05 (0.53%)
Mar 28, 2024, 4:00 PM EDT - Market closed

Company Description

Viemed Healthcare, Inc., together with its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services to patients in the United States.

It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD.

The company leases non-invasive and invasive ventilators, positive airway pressure machines (PAP), durable medical equipment, percussion vests, oxygen concentrators, and other medical equipment; and sells and rents HME devices.

In addition, it provides neuromuscular care and oxygen therapy services; and sleep apnea management provides sleep solutions and/or equipment, such as PAP, automatic continuous positive airway pressure, and bi-level positive airway pressure machines.

Further, the company offers in home sleep apnea testing services, as well as healthcare staffing and recruitment services.

Viemed Healthcare, Inc. was founded in 2006 and is headquartered in Lafayette, Louisiana.

Viemed Healthcare, Inc.
Viemed Healthcare logo
Country United States
Founded 2006
Industry Medical Devices
Sector Healthcare
Employees 996
CEO Casey Hoyt

Contact Details

Address:
625 E. Kaliste Saloom Rd.
Lafayette, Louisiana 70508
United States
Phone 337.504.3802
Website viemed.com

Stock Details

Ticker Symbol VMD
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001729149
CUSIP Number 92663R105
ISIN Number CA92663R1055
SIC Code 8090

Key Executives

Name Position
Casey Hoyt Chief Executive Officer and Director
Michael B. Moore CRT President
Trae Paul Fitzgerald Chief Financial Officer
William Todd Zehnder Chief Operating Officer and Director
Dr. William Dana Frazier M.D. Chief Medical Officer and Director
Jeremy Trahan Chief Legal Officer and Executive Vice President of Acquisitions and Strategic Transactions
Michael Freeman Chief Business Development Officer
Patrick Ewell Eagan General Counsel and Corporate Secretary

Latest SEC Filings

Date Type Title
Mar 11, 2024 8-K Current Report
Mar 6, 2024 10-K Annual Report
Mar 6, 2024 8-K Current Report
Feb 15, 2024 SC 13D/A [Amend] General statement of acquisition of beneficial ownership
Feb 15, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals
Feb 14, 2024 SC 13G Statement of acquisition of beneficial ownership by individuals
Feb 13, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals
Feb 2, 2024 SC 13G Statement of acquisition of beneficial ownership by individuals
Dec 7, 2023 8-K Current Report
Nov 8, 2023 8-K Current Report